CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Down 46.0% in December

CanSino Biologics Inc. (OTCMKTS:CASBF) was the recipient of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 10,800 shares, a decline of 46.0% from the December 15th total of 20,000 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is currently 27.0 days.

CanSino Biologics Stock Up 2.2 %

Shares of OTCMKTS CASBF traded up C$0.07 during trading on Thursday, reaching C$3.37. 765 shares of the stock traded hands, compared to its average volume of 1,153. The company has a 50-day moving average of C$3.91 and a 200-day moving average of C$3.11. CanSino Biologics has a 52-week low of C$1.86 and a 52-week high of C$4.35.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.